Discontinuation of CDK4/6 Inhibitors in Patients With Metastatic HR Positive, HER2 Negative Breast Cancer
Clinical trial NCT06207734 · RECRUITING
Trial details
- NCT number
- NCT06207734
- Sponsor
- Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2024-01-17
- Primary completion
- 2027-01-10
- Enrollment
- 120
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.